Tenderwize
Wróć do wyszukiwania

Open-house rebate agreement for Buserelin

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 05, 2026 · 99 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Buserelin, ATC L02AE01

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

The buyer explicitly states this is an open-house model and not a standard competitive procurement procedure, so usual...

Submission format is strict: either handwritten paper originals in duplicate or electronic submission with a qualified...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2027
  • Non-exclusive open-house rebate agreements for the active substance Buserelin (ATC L02AE01).
  • Supply of pharmaceutical products under a pre-defined contract model.
Pokaż pełne podsumowanie

This is an open-house pharmaceutical supply arrangement for Buserelin (ATC L02AE01) offered by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that no selection among bidders is made and that any pharmaceutical company meeting the stated eligibility conditions may join on identical, non-negotiable terms. The contract term runs from 2025-02-01 to 2027-01-31, with contract entry possible until 2026-12-05. Submission is allowed electronically with a qualified electronic signature or in paper form; documents not in German must be submitted with a German translation. Procurement documents are available via DTVP, but only the notice text was analyzed, not the full document set.

Ryzyka

The buyer explicitly states this is an open-house model and not a standard competitive procurement procedure, so usual...

Submission format is strict: either handwritten paper originals in duplicate or electronic submission with a qualified...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • If the signatory is not authorized in the commercial register, a power of attorney must be provided.

Administrative

  • Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreement for Buserelin

Single lot covering non-exclusive open-house rebate agreements for the medicinal product Buserelin, ATC L02AE01. The scope is pharmaceutical products/supplies in Germany, with performance in Bavaria (DE212). The notice says the contract terms are pre-set and not individually negotiable.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

Jan 2025 - Jan 2027

Kategoria

Pharmaceutical products

Termin

Deadline Dec 05, 2026

Szczegóły zamówienia

Data publikacji
15 Dec 2024
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
768779-2024

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30